The role of the antibody response in influenza virus infection

Current Topics in Microbiology and Immunology

Volumn 260, Issue , 2001, Pages 171-190

  Gerhard, W ^a  

^a WISTAR INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY;

ANTIBODY RESPONSE; B LYMPHOCYTE; DISEASE COURSE; DISEASE PREDISPOSITION; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; INFECTION CONTROL; INFLUENZA; NONHUMAN; PRIMARY INFECTION; PRIORITY JOURNAL; REVIEW; VIRUS NEUTRALIZATION; VIRUS REPLICATION;

INFLUENZA VIRUS;

EID: 0034977654     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-662-05783-4_9     Document Type: Review

References (121)

1. The measurment of haemagglutinin and matrix protein present on the surface of influenza virus infected P815 mastocytoma cells
2. The immune response to influenza infection
3. + T cells
4. Neutralizing antiviral B cell responses
5. Alpha/beta interferons potentiate virus-induced apoptosis through activation of the FADD/Caspase-8 death signaling pathway
6. Immunogenic properties of the small chain HA2 of the hemagglutinin of influenza virus
7. Transgenic mice lacking class I major histocompatibility complex-restricted T cells have delayed viral clearance and increased mortality after influenza virus challenge
8. Murine cytotoxic T lymphocyte recognition of individual influenza virus proteins. High frequency of nonresponder MHC class I alleles
9. Antibody to influenza virus matrix protein detects a common antigen on the surface of cells infected with type A influenza viruses
10. Antibody response to the M2 protein of influenza A virus expressed in insect cells
11. Overview of the mucosal immune system
12. The B-cell system of human mucosae and exocrine glands
13. An analysis of the properties of monoclonal antibodies directed to epitopes on influenza virus hemagglutinin
14. Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity
15. Protection of chickens from lethal influenza infection by vaccinia-expressed hemagglutinin
16. Structure and diversity of influenza virus neuraminidase
17. Involvement of the complement system in the protection of mice from challenge with respiratory syncytial virus long strain following passive immunization with monoclonal antibody 18A2B2
18. Antibody-mediated protection of mucosal surfaces
19. Immunity to influenza in man
20. Recombinant human respiratory syncytial virus (RSV) monoctonal antibody Fab is effective therapeutically when introduced directly into the lungs of RSV-infected mice
21. Host responses to respiratory virus infection and immunization
22. + T-cell mechanisms in the control of respiratory virus infections
23. Clearance of influenza virus respiratory infection in mice lacking class I major histocompatibility complex-restricted CD8 T cells
24. Influenza virus RNA in the lung and lymphoid tissue of immunologically intact and CD4-depleted mice
25. β2-Microglobulindeficient mice can be protected against influenza A infection by vaccination with vaccinia-influenza recombinants expressing hemagglutinin and neuraminidase
26. Mechanisms of protective immunity against influenza virus infection in mice without antibodies
27. IgG isotype distribution of local and systemic immune responses induced by influenza virus infection
28. Modified M2 proteins produce heterotypic immunity against influenza A virus
29. The role of interferon in influenza virus tissue tropism
30. Role of the B cell response in recovery of mice from primary influenza virus infection
31. Resistance to and recovery from lethal influenza virus infection in B lymphocyte-deficient mice
32. Characterization of influenza A/Hong-Kong/156/97(H5N1) virus in a mouse model and protective effect of Zanamivir on H5N1 infection in mice
33. Mice lacking the transcription factor subunit Rel can clear an influenza infection and have functional antiviral cytotoxic T cells but do not develop an optimal antibody response
34. Influenza virus M2 integral membrane protein is a homotetramer stabilized by formation of disulfide bonds
35. Effects of antibody to the influenza A virus M2 protein on M2 surface expression and virus assembly
36. Molecular basis of Fc receptor function
37. Retrovirus-expressed hemagglutinin protects against lethal T (1977) Defense mechanisms againfluenza virus infections
38. Nozimainst primary influenza virus infection in mice. I. Roles of interferon and neutralizing antibodies and thymus dependence of interferon and antibody production
39. Mechanism of immunity to influenza: Maternal and passive neonatal protection following immunization of adult ferrets with a live vaccinia-influenza virus hemagglutinin recombinant but not with recombinants containing other influenza virus proteins
40. Purified influenza virus hemagglutinin and neuraminidase are equivalent in stimulation of antibody response but induce contrasting types of immunity to infection
41. Influenza virus-specific antibody-secreting cells in the murine lung during primary influenza virus infection
42. The B-cell response in lymphoid tissue of mice immunized with various antigenic forms of the influenza virus hemagglutinin
43. Expression of immune mechanisms in the lung
44. Biological activity of monoclonal antibodies to operationally defined antigenic regions on the hemagglutinin molecule of A/Seal/Massachusetts/l/80 (H7N7) influenza virus
45. Isolation and characterization of a novel trypsin-like protease found in rat bronchiolar epithelial Clara cells. A possible activator of the viral fusion glycoprotein
46. DNA vaccine encoding hemagglutinin provides protective immunity against H5N1 influenza virus infection in mice
47. Inhibition of influenza virus haemolytic and haemagglutination activities by monoclonal antibodies to haemagglutinin glycopolypeptides HA1 and HA2
48. Protection and recovery in influenza virus-infected mice immunosuppressed with anti-IgM
49. Passive serum antibody causes temporary recovery from influenza virus infection of the nose, trachea and lung of nude mice
50. Tumor necrosis factor-α up-regulates expression of secretory component, the epithelial receptor for polymeric Ig
51. Interactions of antigens and antibodies at mucosal surfaces
52. Heterosubtypic immunity to influenza type A virus in mice: Effector mechanisms and their longevity
53. A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans
54. Survival of long-lived plasma cells is independent of antigen
55. Th cells primed during influenza virus infection provide help for qualitatively distinct antibody responses to subsequent immunization
56. Intracellular neutralization of influenza virus by immunoglobulin A anti-hemagglutinin monoclonal antibodies
57. Mucosal immunity to influenza virus without IgA: An IgA knockout mouse model
58. In vivo induction of apoptosis by influenza virus
59. + T lymphocytes mediate clearance of virus and regulate the antiviral antibody response
60. A pulmonary influenza virus infection in SCID mice can be cured by treatment with hemagglutinin-specific antibodies that display very low virus-neutralizing activity in vitro
61. + T cells are ineffective in clearing a pulmonary infection with influenza type A virus in the absence of B cells
62. Treatment of influenza virus-infected SCID mice with non-neutralizing antibodies specific for the transmembrane proteins matrix 2 and neuraminidase reduces the pulmonary virus titer but fails to clear the infection
63. Th cell-deficient mice control influenza virus infection more effectively than Th- and B cell-deficient mice: Evidence for a Th-independent contribution by B cells to virus clearance
64. The systemic and mucosal immune response of humans to influenza A virus
65. Orthomyxoviruses
66. The intersubunit region of the influenza virus hemagglutinin is recognized by antibodies during infection
67. A universal influenza A vaccine based on the extracellular domain of the M2 protein
68. Activation of mouse complement by monoclonal mouse antibodies
69. Control of early viral and bacterial distribution and disease by natural antibodies
70. A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains
71. Protection against the mouse-adapted A/FM/1/47 strain of influenza A virus in mice by a monoclonal antibody with cross-neutralizing activity among HI and H2 strains
72. Cytoimmunotherapy for persistent virus infection reveals a unique clearance pattern from the central nervous system
73. Dynamics of B-lymphocytes in the lungs of mice exposed to aerosolized influenza virus
74. Virus-neutralizing antibodies of immunoglobulin G (IgG) but not IgM or IgA isotypes can cure influenza virus pneumonia in SCID mice
75. Effectiveness of topically administered neutralizing antibodies in experimental immunotherapy of respiratory syncytial virus infection in cotton rats
76. Serum antibody prevents lethal murine influenza pneumonitis but not tracheitis
77. Fc Receptors
78. Collectin-mediated antiviral host defense of the lung: Evidence from influenza virus infection of mice
79. Immunoglobulin A mediation of murine nasal anti-influenza virus immunity
80. Passive transfer of local immunity to influenza virus infection by IgA antibody
81. Inhibition of influenza virus replication by nitric oxide
82. Isolation of cross-reactive, subtype-specific monoclonal antibodies against influenza virus HA1 and HA2 hemagglutinin subunits
83. Distinct kinetics of the antibody-forming cell response to Sendai virus infection of mice in different anatomical compartments
84. Administration of anti-IFN-γ antibody to β2-microglobulin-deficient mice delays influenza virus clearance but does not switch the response to a T helper cell 2 phenotype
85. Influenza A virus-induced IFN-α/β and IL-18 synergistically enhance IFN-γ expression in human T cells
86. Crystallographic detection of a second ligand binding site in influenza virus hemagglutinin
87. Mice can recover from pulmonary influenza virus infection in the absence of class I-restricted cytotoxic T cells
88. 2 fragments of protective monoclonal antibodies to yellow fever virus (YF) envelope proteins fail to protect mice against lethal YF encephalitis
89. Variations in the neutralizing and haemagglutination-inhibiting activities of five influenza A virus-specific IgGs and their antibody fragments
90. Protection of mice against influenza A virus challenge by vaccination with baculovirus-expressed M2 protein
91. Humoral immunity due to long-lived plasma cells
92. Interferon-γ enhances expression of secretory component, the epithelial receptor for polymeric immunoglobulins
93. Interferon-induced proteins and the antiviral state
94. Characterization and immunological properties of influenza A virus nucleoprotein (NP): Cell-associated NP isolated from infected cells or viral NP expressed by vaccinia recombinant virus do not confer protection
95. Structural characterization of the M2 protein of influenza A viruses: Evidence that it forms a tetrameric channel
96. T cell-independent antibody-mediated clearance of polyoma virus in T cell-deficient mice
97. Cross-protection against influenza A virus infection by passively transferred respiratory tract IgA antibodies to different hemagglutinin molecules
98. Antibody-forming cells in the nasal-associated lymphoid tissue during primary influenza virus infection
99. Homotypic and heterotypic immunity of influenza A viruses induced by recombinants of the cold-adapted master strain A/AnnArbor/6/60-ca
100. Estimation of the number of surface projections on myxo- and paramyxoviruses
101. + T cell memory in the absence of B cells and Ig
102. + T cells is inefficient in the absence of B cells
103. Passively transferred monoclonal antibody to the M2 protein inhibits influenza A virus replication in mice
104. An antibody which binds to the membrane-proximal end of influenza virus haemagglutinin (H3 subtype) inhibits the low-pH-induced conformational change and cell-cell fusion but does not neutralize virus
105. Host defenses against influenza virus: The role of anti-hemagglutinin antibody
106. Mechanisms of immunity to influenza in experimental animals
107. Early presence of ribonucleoprotein antigen on surface of influenza virus-infected cells
108. Isolation and immunogenic properties of a monomeric form of the HA1 subunit of the influenza virus haemagglutinin from infected cells
109. Cross-protection and cross-reactive cytotoxic T cells induced by influenza virus vaccines in mice
110. Protection against lethal influenza with neuraminidase
111. Recovery from a viral respiratory infection. I. Influenza pneumonia in normal and T-deficient mice
112. Structural basis of immune recognition of influenza virus hemagglutinin
113. The structure and function of the hemagglutinin membrane glycoprotein of influenza virus
114. Expression of influenza A virus internal antigens on the surface of infected P815 cells
115. An avian influenza virus of which infectivity is neutralized by antisera lacking hemagglutination-inhibition activity
116. Mechanisms of cellular penetration and nuclear localization of an anti-double strand DNA autoantibody
117. Influenza A virus M2 protein: Monoclonal antibody restriction of virus growth and detection of M2 in virions
118. Growth restriction of influenza A virus by M2 protein antibody is genetically linked to the MI protein